Researchers from Rice University and Baylor College of Medicine have demonstrated a groundbreaking treatment that eradicates ...

Innovent Biologics has made the case that its checkpoint inhibitor-cytokine fusion protein has a future in colorectal cancer.

GlobalData’s report assesses the drugs in the Interleukin 2 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

Analyst Judah Frommer from Morgan Stanley maintained a Buy rating on Mural Oncology Plc (MURA – Research Report) and keeping the price ...

Cytokines enable communication between immune cells, encouraging their proliferation, differentiation, and functional activation. For example, interleukin-2 (IL-2) improves T cell proliferation and ...

Vivtex to apply its GI-ORIS™ technology to optimize oral bioavailability of EQ302, Equillium’s novel IL-15/IL-21 bi-specific peptide ...

BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class ...

Rice University and Baylor College of Medicine have received $2.8 million in funding from the National Heart, Lung, and Blood ...

The phase IIIA trials randomized 792 patients ages 12 and older with severe asthma in a 2:1 ratio to depemokimab (100 mg ...

Depemokimab was shown to reduce exacerbations in patients with severe asthma. The proportions of adverse events of ...